A treatment planning comparison between modulated tri-cobalt-60 teletherapy and linear accelerator–based stereotactic body radiotherapy for central early-stage non−small cell lung cancer
Catherine Merna(University of California, Los Angeles), Percy Lee(University of California, Los Angeles), Argin Michailian(University of California, Los Angeles), Patrick A. Kupelian, Amar U. Kishan(University of California, Los Angeles), Minsong Cao(Ronald Reagan UCLA Medical Center), Ke Sheng(Wenzhou Medical University), Nzhde Agazaryan(University of California, Los Angeles), Pin‐Chieh Wang(University of California, Los Angeles), Michael L. Steinberg(University of California, Los Angeles), Daniel A. Low(University of California, Los Angeles), Jean-Claude M. Rwigema(University of California, Los Angeles), James Lamb(University of California, Los Angeles)
Cited by 37
Related Papers
Tolerance limits and methodologies for<scp>IMRT</scp>measurement‐based verification<scp>QA</scp>:<i>Recommendations of<scp>AAPM</scp>Task Group No. 218</i>
|Medical Physics|2018|1k
Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG Oncology
|International Journal of Radiation Oncology*Biology*Physics|2020|314
External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline
|Practical Radiation Oncology|2021|261
The transformation of radiation oncology using real-time magnetic resonance guidance: A review
|European Journal of Cancer|2019|182
A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy
|Advances in Radiation Oncology|2018|161